According to a new report from Intel Market Research, the global Poultry Vaccines market was valued at USD 4.413 billion in 2025 and is projected to reach USD 6.109 billion by 2034, exhibiting a robust CAGR of 4.9% during the forecast period (2025–2034). This expansion is driven by the rising global demand for poultry protein, accelerating farm intensification, and increasingly stringent disease‑control regulations worldwide.
Poultry vaccines are biological products designed to prevent or control infectious diseases in chickens, ducks, and turkeys by stimulating protective immunity. The technology portfolio includes live attenuated, inactivated (killed), recombinant vector, subunit, and immune‑complex formats, while delivery methods span drinking‑water spray, eye‑drop, injection, and in‑ovo administration.
📥 Download FREE Sample Report:
Poultry Vaccines Market - View in Detailed Research Report
Comments
Log in or sign up to join the conversation.